Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders, Diffuse Large B-Cell Lymphoma Type, in a Patient with Behçet's Disease Treated with Cyclosporine A.

Behçet's disease Cyclosporine A Diffuse large B-cell lymphoma Epstein-Barr virus Lymph node

Journal

Case reports in oncology
ISSN: 1662-6575
Titre abrégé: Case Rep Oncol
Pays: Switzerland
ID NLM: 101517601

Informations de publication

Date de publication:
Historique:
received: 20 07 2020
accepted: 21 07 2020
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 22 10 2020
Statut: epublish

Résumé

A 40-year-old man had been treated for Behçet's disease (BD) with cyclosporine A (CsA) for 14 years. He presented multiple lymphadenopathies with fever. Histological examination of surgical biopsy showed other iatrogenic immunodeficiency-associated lymphoproliferative disorders, diffuse large B-cell lymphoma type with positivity for Epstein-Barr virus encoding RNA-1 (EBER-1).

Identifiants

pubmed: 33082762
doi: 10.1159/000510362
pii: cro-0013-1145
pmc: PMC7548881
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1145-1151

Informations de copyright

Copyright © 2020 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Références

Neurol Med Chir (Tokyo). 2005 Nov;45(11):586-90
pubmed: 16308519
Acta Derm Venereol. 2010 Nov;90(6):616-20
pubmed: 21057746
Blood Rev. 2017 Mar;31(2):37-42
pubmed: 27717585
J Clin Exp Hematop. 2012;52(3):211-8
pubmed: 23269082
Blood. 2011 Feb 24;117(8):2319-31
pubmed: 21119107
J Clin Oncol. 2013 Nov 1;31(31):e435-8
pubmed: 23775963
Acta Derm Venereol. 2008;88(2):117-20
pubmed: 18311436
Cancer Sci. 2012 Aug;103(8):1567-73
pubmed: 22500644
Clin Rheumatol. 2001;20(4):239-44
pubmed: 11529628
Int J Rheum Dis. 2014 May;17(4):459-65
pubmed: 24354961
J Clin Exp Hematop. 2019;59(2):72-92
pubmed: 31257348
J Drugs Dermatol. 2010 Oct;9(10):1277-81
pubmed: 20941955
Rheumatol Int. 2010 Apr;30(6):831-5
pubmed: 20016987
Am J Surg Pathol. 2018 Jul;42(7):936-950
pubmed: 29738359
Dermatology. 2006;213(3):239-41
pubmed: 17033176
Diagn Pathol. 2020 Apr 7;15(1):34
pubmed: 32264892
Intern Med. 2018 Feb 15;57(4):601-604
pubmed: 29269644
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):336-8
pubmed: 16460502

Auteurs

Yuka Urano (Y)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.

Rintaro Ohe (R)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.

Akane Yamada (A)

Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.

Takanobu Kabasawa (T)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.

Kazushi Suzuki (K)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.

Takumi Kitaoka (T)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.

Nobuyuki Tamazawa (N)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.

Naing Ye Aung (NY)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.

Aya Utsunomiya (A)

Department of Pathological Diagnostics, Yamagata University Faculty of Medicine, Yamagata, Japan.

Tomomi Toubai (T)

Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.

Kenichi Ishizawa (K)

Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.

Classifications MeSH